Re: The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multicenter, Prospective Registry Study von Ishizuka, Yumiko, Horimoto, Yoshiya

Volltext

Microsatellite instability and mismatch repair protein expressions in lymphocyte‐predominant breast cancer von Horimoto, Yoshiya, Thinzar Hlaing, May, Saeki, Harumi, Kitano, Shigehisa, Nakai, Katsuya, Sasaki, Ritsuko, Kurisaki‐Arakawa, Aiko, Arakawa, Atsushi, Otsuji, Naomi, Matsuoka, Shuji, Tokuda, Emi, Arai, Masami, Saito, Mitsue

Volltext

Intrinsic subtype distribution should vary according to institutions von Horimoto, Yoshiya, Tanabe, Masahiko

Volltext

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients von Horimoto, Yoshiya, Ishizuka, Yumiko, Ueki, Yuko, Higuchi, Toru, Arakawa, Atsushi, Saito, Mitsue

Volltext

Differences in Ki67 expressions between pre- and post-neoadjuvant chemotherapy specimens might predict early recurrence of breast cancer von Tokuda, Emi, MD, Horimoto, Yoshiya, MD, Arakawa, Atsushi, MD, Himuro, Takanori, MD, Senuma, Koji, MD, Nakai, Katsuya, MD, Saito, Mitsue, MD

Volltext

Plasma cell infiltration and treatment effect in breast cancer patients treated with neoadjuvant chemotherapy von Sakaguchi, Asumi, Horimoto, Yoshiya, Onagi, Hiroko, Ikarashi, Daiki, Nakayama, Takayuki, Nakatsura, Tetsuya, Shimizu, Hideo, Kojima, Kuniaki, Yao, Takashi, Matsumoto, Toshiharu, Ogura, Kanako, Kitano, Shigehisa

Volltext

Some pathological and clinical factors are important to describe association between Ki67 expression and recurrences in breast cancer patients receiving neoadjuvant chemotherapy—re... von Horimoto, Yoshiya, MD, PhD

Volltext

Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases von Horimoto, Yoshiya, Arakawa, Atsushi, Sasahara, Noriko, Tanabe, Masahiko, Sai, Sei, Himuro, Takanori, Saito, Mitsue

Volltext

Short somatic alterations at the site of copy number variation in breast cancer von Murakami, Fumi, Tsuboi, Yumi, Takahashi, Yuka, Horimoto, Yoshiya, Mogushi, Kaoru, Ito, Takeshi, Emi, Mitsuru, Matsubara, Daisuke, Shibata, Tatsuhiro, Saito, Mitsue, Murakami, Yoshinori

Volltext

High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs von Onagi, Hiroko, Horimoto, Yoshiya, Sakaguchi, Asumi, Ikarashi, Daiki, Yanagisawa, Naotake, Nakayama, Takayuki, Nakatsura, Tetsuya, Ishizuka, Yumiko, Sasaki, Ritsuko, Watanabe, Junichiro, Saito, Mitsue, Saeki, Harumi, Hayashi, Takuo, Arakawa, Atsushi, Yao, Takashi, Kitano, Shigehisa

Volltext

Characterization of breast cancer tumors in older patients who show de novo resistance to endocrine therapy von Ishizuka, Yumiko, Horimoto, Yoshiya, Yuan, Men, Ueki, Yuko, Onagi, Hiroko, Saeki, Harumi, Hayashi, Takuo, Saito, Tsuyoshi, Kawate, Takahiko, Ishikawa, Takashi, Eguchi, Hidetaka, Watanabe, Junichiro, Kutomi, Goro

Volltext

Carcinoma-associated fibroblasts are a promising therapeutic target von Togo, Shinsaku, Polanska, Urszula M, Horimoto, Yoshiya, Orimo, Akira

Volltext

Feasibility of Quantitative MRI Using 3D‐QALAS for Discriminating Immunohistochemical Status in Invasive Ductal Carcinoma of the Breast von Amano, Maki, Fujita, Shohei, Takei, Naoyuki, Sano, Katsuhiro, Wada, Akihiko, Sato, Kanako, Kikuta, Junko, Kuwatsuru, Yoshiki, Tachibana, Rina, Sekine, Towa, Horimoto, Yoshiya, Aoki, Shigeki

Volltext

High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer von Horimoto, Yoshiya, Sasahara, Noriko, Sasaki, Ritsuko, Hlaing, May Thinzar, Sakaguchi, Asumi, Saeki, Harumi, Arakawa, Atsushi, Himuro, Takanori, Saito, Mitsue

Volltext

Metastatic breast tumors from extramammary malignancies: a case series von Semba, Ryoko, Horimoto, Yoshiya, Arakawa, Atsushi, Saito, Mitsue

Volltext

Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot stu... von Horimoto, Yoshiya, Tokuda, Emi, Murakami, Fumi, Uomori, Toshitaka, Himuro, Takanori, Nakai, Katsuya, Orihata, Gotaro, Iijima, Kotaro, Togo, Shinsaku, Shimizu, Hideo, Saito, Mitsue

Volltext

IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells von Itoh, Takumi, Hatano, Ryo, Horimoto, Yoshiya, Yamada, Taketo, Song, Dan, Otsuka, Haruna, Shirakawa, Yuki, Mastuoka, Shuji, Iwao, Noriaki, Aune, Thomas M., Dang, Nam H., Kaneko, Yutaro, Okumura, Ko, Morimoto, Chikao, Ohnuma, Kei

Volltext

Tamoxifen-resistant breast cancer cells exhibit reactivity with Wisteria floribunda agglutinin von Hlaing, May Thinzar, Horimoto, Yoshiya, Denda-Nagai, Kaori, Fujihira, Haruhiko, Noji, Miki, Kaji, Hiroyuki, Tomioka, Azusa, Ishizuka, Yumiko, Saeki, Harumi, Arakawa, Atsushi, Saito, Mitsue, Irimura, Tatsuro

Volltext

Stromal Ki67 Expression Might be a Useful Marker for Distinguishing Fibroadenoma From Benign Phyllodes Tumor of the Breast von Yuan, Men, Saeki, Harumi, Horimoto, Yoshiya, Ishizuka, Yumiko, Onagi, Hiroko, Saito, Mitsue, Hayashi, Takuo, Arakawa, Atsushi, Yao, Takashi

Volltext

Clinicopathological Features Related to the Efficacy of CDK4/6 Inhibitor-Based Treatments in Metastatic Breast Cancer von Shikanai, Ayana, Horimoto, Yoshiya, Ishizuka, Yumiko, Uomori, Toshitaka, Nakai, Katsuya, Arakawa, Atsushi, Saito, Mitsue

Volltext